EDELMAN JOSEPH 4
4 · LeonaBio, Inc. · Filed Jun 24, 2026
Research Summary
AI-generated summary of this filing
LeonaBio (LONA) Director Joseph Edelman Receives 28,000-Share Option
What Happened
- Joseph Edelman, a director of LeonaBio, was granted a derivative award on 2026-06-23: an option covering 28,000 shares reported at $0.00. The grant is an award under the company’s Outside Director Compensation Policy and is not a sale or cash purchase.
Key Details
- Transaction date: 2026-06-23; Form 4 filed: 2026-06-24 (timely).
- Reported instrument: derivative award (option) for 28,000 shares; reported price $0.00 on the filing.
- Vesting: the option vests on the earlier of (i) June 23, 2027, or (ii) the day before the next annual meeting of stockholders after June 22, 2026 (per footnote).
- Shares owned after transaction: not specified in the provided filing details.
- No 10b5-1, no exercise/sale, and no tax-withholding reported in this transaction.
Context
- This is a routine director compensation grant — not an exercise or sale — and doesn’t indicate an immediate cash commitment or sale of shares. Such awards commonly vest over time and are used to compensate non-employee directors.
Insider Transaction Report
Form 4
LeonaBio, Inc.LONA
EDELMAN JOSEPH
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-06-23+28,000→ 28,000 totalExercise: $8.35Exp: 2036-06-22→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.
Signature
/s/ Mark Worthington, Attorney in fact for Joseph Edelman|2026-06-24